-
Founded in:
1995-12-26 -
Country:
China -
Address:
Room 101, 1st-5th Floor, Building 5, No. 13 Guangyuan West Street, Tongzhou District, Beijing -
Tax NO.:
91110112102444497K -
Registered Funds:
250 million yuan -
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Podophyllotoxin |
This product is a plant extract and a cell division inhibitor in the metaphase of cell division. In vitro and in vivo tests have proven that this product has anti-tumor activity, can inhibit microtubule polymerization, inhibit nuclear mitosis, and stop it in the metaphase. When used externally to treat condyloma acuminatum, it can inhibit the division and proliferation of epithelial cells in warty proliferation caused by human papillomavirus (HPV) infection, causing necrosis and shedding, thereby playing a therapeutic role.
More
This product is a plant extract and a cell division inhibitor in the metaphase of cell division. In vitro and in vivo tests have proven that this product has anti-tumor activity, can inhibit microtubule polymerization, inhibit nuclear mitosis, and stop it in the metaphase. When used externally to treat condyloma acuminatum, it can inhibit the division and proliferation of epithelial cells in warty proliferation caused by human papillomavirus (HPV) infection, causing necrosis and shedding, thereby playing a therapeutic role. |
518-28-5 | 7 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Naloxone hydrochloride |
1. Completely or partially correct the central inhibitory effects of opioids. Such as respiratory depression, sedation and hypotension. 2. It has a wake-promoting effect on animals with acute ethanol poisoning. 3. It is a pure opioid receptor antagonist, that is, it does not have the excitatory or morphine-like effects of other opioid receptor antagonists; it does not cause respiratory depression, psychotomimetic reactions or mydriasis reactions. 4. No drug tolerance is observed, nor is there any physiological or psychological dependence. 5. Although the mechanism of action is not fully understood, there is sufficient evidence to show that it antagonizes the effects of opioids by competing for the same receptor sites.
More
1. Completely or partially correct the central inhibitory effects of opioids. Such as respiratory depression, sedation and hypotension. 2. It has a wake-promoting effect on animals with acute ethanol poisoning. 3. It is a pure opioid receptor antagonist, that is, it does not have the excitatory or morphine-like effects of other opioid receptor antagonists; it does not cause respiratory depression, psychotomimetic reactions or mydriasis reactions. 4. No drug tolerance is observed, nor is there any physiological or psychological dependence. 5. Although the mechanism of action is not fully understood, there is sufficient evidence to show that it antagonizes the effects of opioids by competing for the same receptor sites. |
357-08-4 | 32 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Sodium sulphonate |
Opioid receptor specific antagonist, small dose (0.4-0.8 mg) intramuscular or intravenous injection can quickly reverse the effect of morphine, intravenous injection for 1-3 minutes can eliminate respiratory depression and increase respiratory rate. It has a wake-up effect on animals with acute alcohol poisoning.
More
Opioid receptor specific antagonist, small dose (0.4-0.8 mg) intramuscular or intravenous injection can quickly reverse the effect of morphine, intravenous injection for 1-3 minutes can eliminate respiratory depression and increase respiratory rate. It has a wake-up effect on animals with acute alcohol poisoning. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Sodium sulphonate |
Opioid receptor specific antagonist, small dose (0.4-0.8 mg) intramuscular or intravenous injection can quickly reverse the effect of morphine, intravenous injection for 1-3 minutes can eliminate respiratory depression and increase respiratory rate. It has a wake-up effect on animals with acute alcohol poisoning.
More
Opioid receptor specific antagonist, small dose (0.4-0.8 mg) intramuscular or intravenous injection can quickly reverse the effect of morphine, intravenous injection for 1-3 minutes can eliminate respiratory depression and increase respiratory rate. It has a wake-up effect on animals with acute alcohol poisoning. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| tremella polysaccharide |
This product is a basidiomycete polysaccharide immunopotentiator, which has the effect of improving the body's immune function and increasing white blood cells. Animal experimental studies have shown that it can treat leukocytopenia caused by hydrochloric acid nitrogen mustard and cyclophosphamide in rabbits; it can promote the recovery of hematopoietic function of mice, dogs, and monkeys after γ-ray irradiation and improve the survival rate; it can significantly improve the phagocytic function of mouse reticuloendothelial cells, increase the number of monkey peripheral lymphocytes, the formation rate of E rosettes and EAC rosettes in macaque peripheral blood, increase the level of immunoglobulins and serum total complement, and has a preventive and therapeutic effect on leukocytopenia in rats caused by cyclophosphamide; it has the effect of promoting antibody production in normal and tumor-bearing mice, can activate spleen function, and enhance specific and non-specific immune responses.
More
This product is a basidiomycete polysaccharide immunopotentiator, which has the effect of improving the body's immune function and increasing white blood cells. Animal experimental studies have shown that it can treat leukocytopenia caused by hydrochloric acid nitrogen mustard and cyclophosphamide in rabbits; it can promote the recovery of hematopoietic function of mice, dogs, and monkeys after γ-ray irradiation and improve the survival rate; it can significantly improve the phagocytic function of mouse reticuloendothelial cells, increase the number of monkey peripheral lymphocytes, the formation rate of E rosettes and EAC rosettes in macaque peripheral blood, increase the level of immunoglobulins and serum total complement, and has a preventive and therapeutic effect on leukocytopenia in rats caused by cyclophosphamide; it has the effect of promoting antibody production in normal and tumor-bearing mice, can activate spleen function, and enhance specific and non-specific immune responses. |
9075-53-0 | 0 |